B2VE98 AF NFT

Dual-specificity RNA methyltransferase RlmN

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeicgcuhqldsltaiewafhzrbiuvfzae5asi4clznrcggqojiketc4iy/metadata.json
IPFS of structure file: 
bafybeibw3s2bgj5m7723wcldidluy2zccwphnx4d5txktv6lgdh4trbrdy/AF-B2VE98-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xf4ED13986579E8e227b3ED6c02276c648754EC27
First NFT owner address (bech32): 
genesis17nk38xr9085wyfana4kqyfmvvjr4fmp80usw7n
Current NFT ID #378270 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
378270
Accession (UniProt):
B2VE98
Name::
Dual-specificity RNA methyltransferase RlmN
Experimental Method:
Predicted structure
Sequence source:
Erwinia tasmaniensis (strain DSM 17950 / CFBP 7177 / CIP 109463 / NCPPB 4357 / Et1/99)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2VE98 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2VE98|RLMN_ERWT9 Dual-specificity RNA methyltransferase RlmN OS=Erwinia tasmaniensis (strain DSM 17950 / CFBP 7177 / CIP 109463 / NCPPB 4357 / Et1/99) OX=465817 GN=rlmN PE=3 SV=1 MSELNVTPSSVSPEIVIPKKEKINLLDLNRQQMREFFAGLGEKPFRADQVMKWIYHYCCDDFDEMTDINKVFRNRLKELAEIRAPEVAEEQRSSDGTIKWAIQVGGQQVETVYIPEKDRATLCVSSQVGCALECKFCSTAQQGFNRNLRVSEIIGQVWRAAKIIGATKVIGQRPITNVVMMGMGEPLLNLTNVVPAMEIMLDDFGFGLSKRRVTLSTSGVVPALDKLGDMIDVALAISLHAPNDTIRDEIVPINKKYNIETFLASVSRYIGKSNANQGRVTIEYVMLDHINDSTDNAHELAALLKETPCKINLIPWNPFPGAPYGRSSNSRIDRFSKVLMEYGFTTIVRKTRGDDIDAACGQLAGDVIDRTKRTLKKKMAGEAISVKAL